Transvenous Lead Extraction in the Left Ventricular Assist Device Patient Posted on July 8th, 2024 by LEADconnection Post navigation Previous: Inflammatory biomarkers as predictors of systemic vs isolated pocket infection in patients undergoing transvenous lead extractionNext: Trends and disparities in cardiac implantable electronic device infection-related mortality in the United States
Inflammatory biomarkers as predictors of systemic vs isolated pocket infection in patients undergoing transvenous lead extraction Posted on July 8th, 2024 by LEADconnection Post navigation Previous: Staphylococcus aureus bacteraemia, cardiac implantable electronic device, extraction, and the risk of recurrent infection; a retrospective population-based cohort studyNext: Transvenous Lead Extraction in the Left Ventricular Assist Device Patient
Staphylococcus aureus bacteraemia, cardiac implantable electronic device, extraction, and the risk of recurrent infection; a retrospective population-based cohort study Posted on July 8th, 2024 by LEADconnection Post navigation Previous: Outcomes of combined left bundle branch area pacing with atrioventricular nodal ablation in patients with atrial fibrillation and pulmonary diseaseNext: Inflammatory biomarkers as predictors of systemic vs isolated pocket infection in patients undergoing transvenous lead extraction
